How to Choose a Contract Manufacturer for a Liposomal Vitamin C Supplement: A Brand Owner’s Buyer’s Guide

How to Choose a Contract Manufacturer for a Liposomal Vitamin C Supplement: A Brand Owner’s Buyer’s Guide

Direct answer: A brand owner choosing a contract manufacturer for a liposomal vitamin C supplement should verify three things: phospholipid encapsulation technology with DLS particle-size data on every batch, NanoVerify or equivalent nano-process certification, and a CoA that includes encapsulation efficiency alongside standard assay and microbial limits. Certifications, format fit and halal chain documentation complete the picture.

Liposomal vitamin C occupies a premium tier in the supplement market, and the manufacturing capability behind it is not the same as standard ascorbic acid blending. A contract manufacturer that simply mixes vitamin C powder into a liquid and labels it “liposomal” without verified encapsulation is selling a standard product at a premium price. The buyer’s job is to tell the difference before signing.

This guide walks through the five evaluation areas a brand owner should work through when shortlisting a liposomal vitamin C contract manufacturer: encapsulation technology, certifications and quality systems, particle-size verification, format options, and what the published research actually shows.

What Makes Liposomal Vitamin C Different to Manufacture

Standard vitamin C manufacturing is straightforward: ascorbic acid or a mineral ascorbate is blended into a powder, dissolved into a liquid, or compressed into a chewable tablet. The active is water-soluble, stable in dry form, and well understood across the industry.

Liposomal vitamin C adds a phospholipid encapsulation step. The vitamin C is enclosed inside microscopic phospholipid bilayers — structurally similar to cell membranes — which requires specialised processing equipment, controlled temperature and pH conditions, and a phospholipid input material (typically sunflower or soy lecithin). The resulting liposomes must be uniform in size, stable in the finished product, and verifiable through analytical testing.

This means a contract manufacturer making liposomal vitamin C needs capabilities beyond standard blending: encapsulation process development, particle-size analysis equipment, and stability testing that accounts for the phospholipid matrix as well as the active. Not every OEM that lists “liposomal” on its website has these in-house.

Encapsulation Technology: How to Verify a Genuine Liposomal Process

The single most important question to ask a prospective manufacturer is: how do you prove the liposomes exist? A credible answer involves dynamic light scattering (DLS) — an analytical technique that measures particle-size distribution in a liquid sample. A genuine liposomal product will show a defined particle-size peak in the nanometre range, typically reported as Z-average and polydispersity index (PDI). Ask to see a DLS report from a production batch, not just a pilot run.

Beyond DLS, a manufacturer should be able to document the phospholipid input (identity and specification), the encapsulation method, and the encapsulation efficiency — the percentage of vitamin C actually incorporated into liposomes versus free in solution. A CoA that reports vitamin C assay but says nothing about encapsulation efficiency is a red flag: it describes a standard vitamin C product, not a liposomal one.

For brands evaluating a Malaysian manufacturer, NanoVerify certification is an additional layer of third-party validation. NanoVerify is a voluntary certification scheme that verifies a nano-processed product has been manufactured using genuine nanotechnology. A manufacturer holding NanoVerify has undergone independent assessment of its nano-process, which is directly relevant to liposomal production.

In Bionutricia’s own comparative testing, up to twice the bioavailability of standard vitamin C has been observed for the company’s Herbosomal® liposomal vitamin C formulation. This is the manufacturer’s own internal data, not a published clinical trial, and it is specific to Bionutricia’s Herbosomal® process — not a general property of all liposomal vitamin C products. A brand owner evaluating any manufacturer should ask for that manufacturer’s own encapsulation and bioavailability data rather than assuming it transfers across suppliers.

Certifications and Quality Systems to Demand

A liposomal vitamin C contract manufacturer should hold the same baseline certifications as any supplement OEM — and ideally more. The minimum a brand owner should verify:

The certifications row is the same for both product types — FSSC 22000, GMP, HACCP, JAKIM halal, US FDA and MeSTI are baseline expectations for any reputable Malaysian supplement OEM. What changes for liposomal is the additional verification layer: NanoVerify and per-batch particle-size data that standard vitamin C manufacturing does not require.

Format Options for Liposomal Vitamin C

Liposomal vitamin C is a liquid-based formulation, which constrains the range of finished formats a manufacturer can offer. The formats that genuinely suit liposomal vitamin C:

• Liquid sachets — single-serve doses in tear-and-squeeze sachets. The most common liposomal format; convenient, portable, and dose-controlled.
• Liquid bottles — multi-dose bottles with a measuring cap or dropper. Suitable for daily-use products where a sachet format is impractical.
• Gel sachets — a thicker consistency that some brands prefer for sensory differentiation. Requires a manufacturer with gel-formulation capability.
• Pouch beverages — larger-format single-serve drinks. Works for products positioned as functional beverages rather than supplements.

Formats that do not suit liposomal vitamin C include powder sachets and chewable tablets — the liposomal structure is a liquid-phase phenomenon, and drying a liposomal liquid into a powder or compressing it into a tablet disrupts the phospholipid bilayers. A manufacturer offering “liposomal vitamin C powder” should be asked to explain how the liposomal structure survives drying.

What the Research Shows

Published human clinical evidence supports the rationale for liposomal vitamin C as a delivery format. A double-blind, placebo-controlled, randomized trial reported that liposomal delivery enhances absorption of vitamin C into plasma and leukocytes (European journal of nutrition, 2024; PMID 39237620). A separate randomized controlled trial evaluating liposomal and non-liposomal ascorbic acid found enhanced bioavailability for the liposomal form (Journal of liposome research, 2021; PMID 32901526).

A systematic review on vitamin C supplement forms is published in Nutrients (2025; PMID 39861409), and a pharmacokinetic study on liposomal multivitamin formulations is published in Nutrients (2023; PMID 37447400). These records exist as published literature on the topic.

It is worth noting that these studies examine liposomal vitamin C as a delivery format — they do not evaluate any specific manufacturer’s formulation, and bioavailability outcomes may vary with phospholipid composition, particle size, encapsulation efficiency and dose. A brand owner should ask a prospective manufacturer for its own batch-level data rather than relying on published studies alone.

Manufacturing a Liposomal Vitamin C Supplement Under Your Own Brand

Bionutricia offers OEM and ODM contract manufacturing for liposomal vitamin C supplements from its integrated facility in Sungai Buloh, Selangor, Malaysia. The company’s Herbosomal® — Bionutricia’s proprietary liposomal encapsulation and sustained-release technology (registered trademark; patent-pending PI2023005773) — is available for vitamin C formulations, and the facility holds FSSC 22000, GMP, HACCP, JAKIM Halal, US FDA, MeSTI and NanoVerify certifications. Approved formats for liposomal vitamin C include liquid sachets, liquid bottles, gel sachets and pouch beverages. Formulation development, private-label manufacturing and full CoA documentation — including DLS particle-size data — are provided as part of the OEM service. To request a quotation, email ng@bio-nutricia.com or submit an enquiry through the enquiries page on the Bionutricia website.

Frequently Asked Questions

What is the difference between liposomal and standard vitamin C in contract manufacturing?

Standard vitamin C manufacturing involves blending ascorbic acid into a powder, liquid or chewable tablet. Liposomal vitamin C adds a phospholipid encapsulation step that requires specialised equipment, particle-size analysis and encapsulation efficiency testing. A manufacturer making liposomal vitamin C should provide DLS data and encapsulation efficiency on the CoA — a standard vitamin C manufacturer does not need these capabilities.

How do I verify a manufacturer is making genuine liposomal vitamin C?

Ask for a DLS (dynamic light scattering) report from a production batch showing particle-size distribution in the nanometre range, and ask for encapsulation efficiency data on the CoA. NanoVerify certification provides additional third-party validation of the nano-process. A manufacturer that cannot produce either is likely selling a standard vitamin C product with a liposomal label.

What certifications should a liposomal vitamin C contract manufacturer hold?

The baseline is FSSC 22000, GMP, HACCP, JAKIM Halal (for the Malaysian halal market), US FDA registration (for US export) and MeSTI. For liposomal specifically, NanoVerify certification is an additional layer that verifies the nano-process is genuine. These certifications should be current and auditable — ask for certificate numbers and expiry dates.

Which formats work for liposomal vitamin C?

Liposomal vitamin C is a liquid-phase formulation, so the formats that work are liquid sachets, liquid bottles, gel sachets and pouch beverages. Powder sachets and chewable tablets are not suitable because drying or compressing a liposomal liquid disrupts the phospholipid bilayers that define the format.

What should I specify on the CoA for a liposomal vitamin C product?

A liposomal vitamin C CoA should include everything a standard vitamin C CoA carries — vitamin C assay, microbial limits, heavy metals — plus two liposomal-specific parameters: particle-size distribution (Z-average and PDI from DLS) and encapsulation efficiency (percentage of vitamin C incorporated into liposomes). Without these, the CoA describes a standard product, not a liposomal one.

Related Guides

• Liposomal Vitamin C OEM in 2026: Bioavailability Evidence, Particle-Size Verification, and What to Specify on the Contract
• Liposomal Supplement OEM: What Brand Owners Should Know Before Choosing a Manufacturer
• Phytosome vs Liposomal Delivery: Which Absorption Tech Wins for Botanicals?

Article by Bionutricia R&D Team. Last updated: 2026-10-08.